A23V2250/71

NUTRITIONAL COMPOSITIONS, THEIR USE IN REDUCING METABOLIC STRESS AND METHOD OF REDUCING METABOLIC STRESS
20220000164 · 2022-01-06 ·

The present invention concerns a nutritional composition, for example a synthetic nutritional composition, for use in reducing the metabolic stress. This composition is for use in mammals, preferably in humans, more preferably in infants. The nutritional composition comprises one or more medium chain fatty acid (MCFA) derivative or derivatives for use in reducing metabolic stress. Conditions and/or diseases associated to the metabolic disorders and/or imbalances in an infant are selected in the group consisting of neurological, growth and/or gut retarded development or abnormalities, hypoglycemia, hyperglycemia, hyperinsulinemia, hypertriglyceridemia. The infant is born preterm or with low-birthweight (LBW) or who experienced intra-uterine growth retardation (IUGR) or small for gestational age (SGA)).

NUTRITIONAL COMPOSITIONS, THEIR USE IN REDUCING METABOLIC STRESS AND METHOD OF REDUCING METABOLIC STRESS
20220000164 · 2022-01-06 ·

The present invention concerns a nutritional composition, for example a synthetic nutritional composition, for use in reducing the metabolic stress. This composition is for use in mammals, preferably in humans, more preferably in infants. The nutritional composition comprises one or more medium chain fatty acid (MCFA) derivative or derivatives for use in reducing metabolic stress. Conditions and/or diseases associated to the metabolic disorders and/or imbalances in an infant are selected in the group consisting of neurological, growth and/or gut retarded development or abnormalities, hypoglycemia, hyperglycemia, hyperinsulinemia, hypertriglyceridemia. The infant is born preterm or with low-birthweight (LBW) or who experienced intra-uterine growth retardation (IUGR) or small for gestational age (SGA)).

Nutritional formulations and kits for bariatric individuals
11213059 · 2022-01-04 · ·

The present technology relates to a nutritional formulation for administration to bariatric individuals. The nutritional formulation includes a multi-nutrients dosage unit; and a minerals dosage unit.

Vitamin D-fortified water and method of manufacturing thereof
11638439 · 2023-05-02 · ·

The present invention relates to a drinking product of vitamin D-fortified mineral water. The present invention further relates to methods of preparing packaged drinking product of the vitamin D-fortified water with minerals and/or natural mineral water, wherein the method essentially comprises water treatment, re-mineralization, ozonation, vitamin D dosing, and mineralization.

Vitamin D-fortified water and method of manufacturing thereof
11638439 · 2023-05-02 · ·

The present invention relates to a drinking product of vitamin D-fortified mineral water. The present invention further relates to methods of preparing packaged drinking product of the vitamin D-fortified water with minerals and/or natural mineral water, wherein the method essentially comprises water treatment, re-mineralization, ozonation, vitamin D dosing, and mineralization.

MYO-INOSITOL AND THE PREVENTION OF PPROM

The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of a preterm-onset pre-labour rupture of membranes (PPROM) and disorders and/or conditions linked thereto. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

MYO-INOSITOL AND THE PREVENTION OF PPROM

The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of a preterm-onset pre-labour rupture of membranes (PPROM) and disorders and/or conditions linked thereto. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

MYO-INOSITOL AND THE PREVENTION OF PRETERM BIRTH

The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of preterm birth and/or of conditions linked to preterm delivery in a female subject and/or in the offspring. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

MYO-INOSITOL AND THE PREVENTION OF PRETERM BIRTH

The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of preterm birth and/or of conditions linked to preterm delivery in a female subject and/or in the offspring. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

DIETARY NUTRIENT COMPOSITIONS

Provided herein are dietary supplement compositions comprising a plurality of beadlets and an oil. Provided herein are also dietary supplement compositions comprising a plurality of mini-tabs and oil. The beadlets or mini-tabs comprise at least one nutrient that is miscible in aqueous solution, and the oil comprises at least one fat-soluble nutrient. The composition may be contained within one or more capsules, and be packaged with a scented insert.